Negative pressure wound therapy and other new therapies for diabetic foot ulceration: The current state of play

Medical Clinics of North America

Volumn 97, Issue 5, 2013, Pages 899-909

  Isaac, Adam L ^a   Armstrong, David G ^a  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

Diabetic foot ulcer; Negative pressure wound therapy; Theragnostics; Wound chemotherapy

Indexed keywords

BIGUANIDE; DOXYCYCLINE; INSULIN; PROTEINASE;

ANTIMICROBIAL ACTIVITY; DIABETIC FOOT; HUMAN; LIMB SALVAGE; PRIORITY JOURNAL; REVIEW; SPLIT THICKNESS SKIN GRAFT; VACUUM ASSISTED CLOSURE; WOUND CARE; WOUND DRESSING; WOUND HEALING;

DIABETIC FOOT ULCER; NEGATIVE PRESSURE WOUND THERAPY; THERAGNOSTICS; WOUND CHEMOTHERAPY;

DIABETIC FOOT; EVIDENCE-BASED MEDICINE; FOOT ULCER; HUMANS; NEGATIVE-PRESSURE WOUND THERAPY; QUALITY OF HEALTH CARE; WOUND HEALING;

EID: 84883244213     PISSN: 00257125     EISSN: 15579859     Source Type: Journal    
DOI: 10.1016/j.mcna.2013.03.015     Document Type: Review

References (42)

1. International Diabetes Federation IDF diabetes atlas 2011, International Diabetes Federation, Brussels (Belgium), Available at:, Accessed on January 5, 2013. http://www.idf.org/diabetesatlas, 5th edition.
2. Centers for Disease Control and Prevention National diabetes fact sheet: national estimates and general information on diabetes and prediabetes in the United States, 2011 2011, U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, Atlanta (GA).
3. Singh N., Armstrong D.G., Lipsky B.A. Preventing foot ulcers in patients with diabetes. JAMA 2005, 293(2):217-228.
4. Lavery L.A., Armstrong D.G., Wunderlich R.P., et al. Risk factors for foot infections in individuals with diabetes. Diabetes Care 2006, 29(6):1288-1293.
5. Driver V.R., Fabbi M., Lavery L.A., et al. The costs of diabetic foot: the economic case for the limb salvage team. JVasc Surg 2010, 52(Suppl 3):17S-22S.
6. Armstrong DG, Kanda VA, Lavery LA, etal. Mind the gap: the disparity between research funding and costs of care for diabetic foot ulcers. Diabetes Care, in press.
7. Iversen M.M., Tell G.S., Riise T., et al. History of foot ulcer increases mortality among individuals with diabetes: ten-year follow-up of the Nord-Trøndelag Health Study, Norway. Diabetes Care 2009, 32(12):2193-2199.
8. Van Gils C.C., Wheeler L.A., Mellstrom M., et al. Amputation prevention by vascular surgery and podiatry collaboration in high-risk diabetic and nondiabetic patients. The Operation Desert Foot experience. Diabetes Care 1999, 22(5):678-683.
9. Armstrong D.G., Wrobel J., Robbins J.M. Guest editorial: are diabetes-related wounds and amputations worse than cancer?. Int Wound J 2007, 4(4):286-287.
10. Armstrong D.G., Mills J.L. Toward a change in syntax in diabetic foot care: prevention equals remission. JAm Podiatr Med Assoc 2013, 103(2):161-162.
11. Rogers L.C., Andros G., Caporusso J., et al. Toe and flow: essential components and structure of the amputation prevention team. JAm Podiatr Med Assoc 2010, 100(5):342-348.
12. Armstrong D.G., Andros G. Use of negative pressure wound therapy to help facilitate limb preservation. Int Wound J 2012, 9(Suppl 1):1-7.
13. Armstrong DG, Attinger CE, Boulton AJ, et al. Guidelines regarding negative wound therapy (NPWT) in the diabetic foot. Ostomy/wound management 50:(4B Suppl),3S.
14. Blitz N.M. Vacuum assisted closure in lower extremity reconstruction. Lower extremity soft tissue and cutaneous plastic surgery 2006, 343-358. Saunders, Edinburgh (United Kingdom). G.L. Dockery, M.E. Crawford (Eds.).
15. V.A.C. Ulta™ Negative Pressure Wound Therapy System. Available at: Accessed on January 5, 2013. http://www.kci1.com/KCI1/vac-ulta.
16. Andros G., Armstrong D.G., Attinger C.E., Tucson Expert Consensus Conference, et al. Consensus statement on negative pressure wound therapy (V.A.C. Therapy) for the management of diabetic foot wounds. Ostomy Wound Manage 2006, (Suppl):1-32.
17. Saxena V., Hwang C.W., Huang S., et al. Vacuum-assisted closure: microdeformations of wounds and cell proliferation. Plast Reconstr Surg 2004, 114(5):1086-1096. [discussion: 1097-8].
18. Olenius M., Dalsgaard C.J., Wickman M. Mitotic activity in expanded human skin. Plast Reconstr Surg 1993, 91(2):213-216.
19. Wysocki A.B., Staiano-Coico L., Grinnell F. Wound fluid from chronic leg ulcers contains elevated levels of metalloproteinases MMP-2 and MMP-9. JInvest Dermatol 1993, 101(1):64-68.
20. Morykwas M.J., Argenta L.C., Shelton-Brown E.I., et al. Vacuum-assisted closure: a new method for wound control and treatment: animal studies and basic foundation. Ann Plast Surg 1997, 38(6):553-562.
21. Weed T., Ratliff C., Drake D.B. Quantifying bacterial bioburden during negative pressure wound therapy: does the wound VAC enhance bacterial clearance?. Ann Plast Surg 2004, 52(3):276-279. [discussion: 279-80].
22. Timmers M.S., Le Cessie S., Banwell P., et al. The effects of varying degrees of pressure delivered by negative-pressure wound therapy on skin perfusion. Ann Plast Surg 2005, 55(6):665-671.
23. Armstrong D.G., Lavery L.A., Diabetic Foot Study Consortium Negative pressure wound therapy after partial diabetic foot amputation: a multicentre, randomized controlled trial. Lancet 2005, 366(9498):1704-1710.
24. Blume P.A., Walters J., Payne W., et al. Comparison of negative pressure wound therapy using vacuum-assisted closure with advanced moist wound therapy in the treatment of diabetic foot ulcers: a multicenter randomized controlled trial. Diabetes Care 2008, 31(4):631-636.
25. Giovinco N.A., Bui T.D., Fisher T., et al. Wound chemotherapy by the use of negative pressure wound therapy and infusion. Eplasty 2010, 10:e9.
26. Scimeca C.L., Bharara M., Fisher T.K., et al. Novel use of doxycycline in continuous-instillation negative pressure wound therapy as "wound chemotherapy". Foot Ankle Spec 2010, 3(4):190-193.
27. Scimeca C.L., Bharara M., Fisher T.K., et al. Novel use of insulin in continuous-instillation negative pressure wound therapy as "wound chemotherapy". JDiabetes Sci Technol 2010, 4(4):820-824.
28. Lessing C., Slack P., Hong K.Z., et al. Negative pressure wound therapy with controlled saline instillation (NPWTi): dressing properties and granulation response invivo. Wounds 2011, 23:309-319.
29. KCI data on file. V.A.C. VeraFlo™ Therapy. Available at: Accessed on January 5, 2013. http://www.kci1.com/KCI1/vac-ulta.
30. Fong K.D., Hu D., Eichstadt S., et al. The SNaP system: biomechanical and animal model testing of a novel ultraportable negative-pressure wound therapy system. Plast Reconstr Surg 2010, 125(5):1362-1371.
31. Lerman B., Oldenbrook L., Eichstadt S.L., et al. Evaluation of chronic wound treatment with the SNaP wound care system versus modern dressing protocols. Plast Reconstr Surg 2010, 126(4):1253-1261.
32. Lerman B., Oldenbrook L., Ryu J., et al. The SNaP Wound Care System: a case series using a novel ultraportable negative pressure wound therapy device for the treatment of diabetic lower extremity wounds. JDiabetes Sci Technol 2010, 4(4):825-830.
33. Armstrong D.G., Marston W.A., Reyzelman A.M., et al. Comparative effectiveness of mechanically and electrically powered negative pressure wound therapy devices: a multicenter randomized controlled trial. Wound Repair Regen 2012, 20(3):332-341.
34. Moisidis E., Heath T., Boorer C., et al. Aprospective, blinded, randomized, controlled clinical trial of topical negative pressure use in skin grafting. Plast Reconstr Surg 2004, 114(4):917-922.
35. Stannard J.P., Volgas D.A., Stewart R., et al. Negative pressure wound therapy after severe open fractures: a prospective randomized study. JOrthop Trauma 2009, 23(8):552-557.
36. Stannard J.P., Atkins B.Z., O'Malley D., et al. Use of negative pressure therapy on closed surgical incisions: a case series. Ostomy Wound Manage 2009, 55(8):58-66. Erratum in: Ostomy Wound Manage. 2009;55(9):6.
37. Gomoll A.H., Lin A., Harris M.B. Incisional vacuum-assisted closure therapy. JOrthop Trauma 2006, 20(10):705-709.
38. Stannard J.P., Volgas D.A., McGwin G., et al. Incisional negative pressure wound therapy after high-risk lower extremity fractures. JOrthop Trauma 2012, 26(1):37-42.
39. Prevena™ incision management system clinician guide 2010, KCI USA, Inc., San Antonio (TX), Accessed on February 13, 2013. http://www.kci1.com/KCI1/elabeling.
40. Armstrong D.G., Giovinco N.A. Diagnostics, theragnostics, and the personal health server: fundamental milestones in technology with revolutionary changes in diabetic foot and wound care to come. Foot Ankle Spec 2011, 4(1):54-60.
41. International consensus The role of proteases in wound diagnostics. An expert working group review 2011, Wounds International, London.
42. Golinko M.S., Margolis D.J., Tal A., et al. Preliminary development of a diabetic foot ulcer database from a wound electronic medical record: a tool to decrease limb amputations. Wound Repair Regen 2009, 17(5):657-665.